Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Omega Healthcare Invts (NYSE:OHI) in the last three months.

In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $33.6, a high estimate of $36.00, and a low estimate of $31.00. Observing a downward trend, the current average is 0.21% lower than the prior average price target of $33.67.

Exploring Analyst Ratings: An In-Depth Overview

The standing of Omega Healthcare Invts among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into Omega Healthcare Invts's market standing. Stay informed and make well-considered decisions with our Ratings Table.

Stay up to date on Omega Healthcare Invts analyst ratings.

Unveiling the Story Behind Omega Healthcare Invts

Financial Insights: Omega Healthcare Invts

Market Capitalization Analysis: Positioned below industry benchmarks, the company's market capitalization faces constraints in size. This could be influenced by factors such as growth expectations or operational capacity.

Positive Revenue Trend: Examining Omega Healthcare Invts's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 1.09% as of 30 September, 2023, showcasing a substantial increase in top-line earnings. When compared to others in the Real Estate sector, the company faces challenges, achieving a growth rate lower than the average among peers.

Net Margin: Omega Healthcare Invts's net margin is impressive, surpassing industry averages. With a net margin of 37.76%, the company demonstrates strong profitability and effective cost management.

Return on Equity (ROE): Omega Healthcare Invts's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 2.51%, the company showcases efficient use of equity capital and strong financial health.

Return on Assets (ROA): Omega Healthcare Invts's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 0.97%, the company showcases efficient use of assets and strong financial health.

Debt Management: Omega Healthcare Invts's debt-to-equity ratio is notably higher than the industry average. With a ratio of 1.44, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.

What Are Analyst Ratings?

Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.

Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.

This article was generated by Benzinga's automated content engine and reviewed by an editor.